Regeneron Pharmaceuticals
REGN·NASDAQ NMS - GLOBAL MARKET
Compare PeersSnapshot
Valuation
Market Cap
P/E (TTM)
P/Sales
EV/EBITDA
P/Book
Cash Flow
Operating CF$5.01B
Free Cash Flow$4.11B
FCF Yield
Margins & Growth
Gross Margin83.18%
Oper. Margin24.32%
Net Margin29.65%
Balance Sheet
Cash$8.75B
Total Assets$40.87B
Total Debt$1.99B
Dividends
Div Yield
DPS (TTM)$2.70
Net Debt$-6.77B
Company Profile
CEO
Dr. Leonard S. Schleifer M.D., Ph.D.
Website
Sector
Health Care
Industry
Biotechnology
Full Time Employees
-
Country
US
Exchange
NASDAQ NMS - GLOBAL MARKET
A Regeneron Pharmaceuticals ocupa um lugar a desenvolver inovações biotecnológicas com medicamentos virados a áreas oncológicas ou oftalmológicas. Os lucros centram as bases com a venda através nos variadíssimos remédios que prescreve perante aprovação contínua.
